Durham-based Biocryst appoints rare disease expert to board
Dr. Thackray currently serves as chief medical officer and senior vice president of clinical development at GlycoMimetics, Inc., a clinical-stage biotechnology company advancing a novel pipeline of orphan drug candidates to address unmet needs for patients.
Read More
